Heron Therapeutics Newsroom

Heron Therapeutics Price Target Maintained With a $4.00/Share by Needham

Dow JonesDec 4 06:56 ET

Heron Therapeutics Analyst Ratings

BenzingaDec 4 06:46 ET

Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 13 09:31 ET

Heron Therapeutics (HRTX) Gets a Buy From Northland Securities

TipRanksNov 13 08:57 ET

Heron Therapeutics Analyst Ratings

BenzingaNov 13 04:43 ET

Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Cuts Target Price to $4

Moomoo NewsNov 12 15:32 ET

Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsSep 26 09:31 ET

Heron Therapeutics Analyst Ratings

BenzingaSep 25 13:42 ET

Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsSep 25 12:32 ET

Heron Therapeutics Analyst Ratings

BenzingaAug 7 06:22 ET

Heron Therapeutics Analyst Ratings

BenzingaJun 13 13:38 ET

Heron Therapeutics Analyst Ratings

BenzingaMay 16 05:31 ET

Analysts Are Bullish on These Healthcare Stocks: AN2 Therapeutics, Inc. (ANTX), Heron Therapeutics (HRTX)

TipRanksMay 15 16:45 ET

Heron Therapeutics Analyst Ratings

BenzingaMay 8 05:37 ET

Heron Therapeutics Analyst Ratings

BenzingaApr 23 07:12 ET

Heron Therapeutics Analyst Ratings

BenzingaApr 11 06:02 ET

Needham Reiterates Buy on Heron Therapeutics, Maintains $5 Price Target

BenzingaApr 11 06:02 ET

Northland Securities Keeps Their Buy Rating on Heron Therapeutics (HRTX)

TipRanksMar 13 09:05 ET

Heron Therapeutics Analyst Ratings

BenzingaMar 13 06:28 ET

Heron Therapeutics (HRTX) Gets a Buy From Northland Securities

TipRanksJan 5 09:15 ET